Trial Details

COMPLETED
Basic Information
Clinical ID c745
Identifier NCT04804540
Trial Title A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis|Crohn Disease
Interventions DRUG: Vedolizumab IV
Participant Information
Sponsor Takeda
City Guntur
Country/Region India
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2021-12-08
Primary Completion Date 2024-02-02
Completion Date 2024-02-02